<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83030</article-id><article-id pub-id-type="doi">10.7554/eLife.83030</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-198397"><name><surname>Lauver</surname><given-names>Matthew D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7001-9730</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198401"><name><surname>Jin</surname><given-names>Ge</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198400"><name><surname>Ayers</surname><given-names>Katelyn N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6156-8685</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274565"><name><surname>Carey</surname><given-names>Sarah N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274566"><name><surname>Specht</surname><given-names>Charles S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274567"><name><surname>Abendroth</surname><given-names>Catherine S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-197743"><name><surname>Lukacher</surname><given-names>Aron E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7969-2841</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>Pennsylvania State University</institution>, <addr-line><named-content content-type="city">Hershey</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>Penn State Milton S. Hershey Medical Center</institution>, <addr-line><named-content content-type="city">Hershey</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-3645"><name><surname>Kirkegaard</surname><given-names>Karla</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>alukacher@pennstatehealth.psu.edu</email> (AL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>11</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e83030</elocation-id><history><date date-type="received"><day>26</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>04</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Lauver et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lauver et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83030-v1.pdf"/><abstract><p>JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease in immunocompromised patients. Inherited and acquired T cell deficiencies are associated with PML. The incidence of PML is increasing with the introduction of new immunomodulatory agents, several of which target T cells or B cells. PML patients often carry mutations in the JCPyV VP1 capsid protein, which confer resistance to neutralizing VP1 antibodies (Ab). Polyomaviruses (PyV) are tightly species-specific; the absence of tractable animal models has handicapped understanding PyV pathogenesis. Using mouse polyomavirus (MuPyV), we found that T cell deficiency during persistent infection, in the setting of monospecific VP1 Ab, was required for outgrowth of VP1 Ab-escape viral variants. CD4 T cells were primarily responsible for limiting polyomavirus infection in the kidney, a major reservoir of persistent infection by both JCPyV and MuPyV, and checking emergence of these mutant viruses. T cells also provided a second line of defense by controlling the outgrowth of VP1 mutant viruses that evaded Ab neutralization. A virus with two capsid mutations, one conferring Ab-escape yet impaired infectivity and a second compensatory mutation, yielded a highly neurovirulent variant. These findings link T cell deficiency and evolution of Ab-escape polyomavirus VP1 variants with neuropathogenicity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5R01NS088367</award-id><principal-award-recipient><name><surname>Lukacher</surname><given-names>Aron E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5R01NS092662</award-id><principal-award-recipient><name><surname>Lukacher</surname><given-names>Aron E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35NS127217</award-id><principal-award-recipient><name><surname>Lukacher</surname><given-names>Aron E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to an approved institutional animal care and use committee (IACUC) protocol  (#PRAMS201447619) of The Pennsylvania State University.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data files are uploaded as Source data files with this manuscript. Images are deposited with Dryad at (https://doi.org/10.5061/dryad.prr4xgxqj).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Lukacher AE</collab><collab>Lauver M</collab><collab>Jin G</collab><collab>Ayers K</collab><collab>Carey S</collab><collab>Specht C</collab><collab>Abendroth C</collab></person-group><year iso-8601-date="2022">2022</year><source>T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.prr4xgxqj">https://dx.doi.org/10.5061/dryad.prr4xgxqj</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.prr4xgxqj</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83030-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>